发明名称 Procedure for the inversion of the stereochemistry at C13 of avermectin aglycone compounds.
摘要 <p>The natural stereochemistry at the 13-position of avermectin aglycones, normally alpha -oriented or below the plane of the molecule, is inverted or epimerized into the beta -position. The procedure starts with the avermectin aglycone compounds where the 13 alpha -hydroxy group is substituted with a leaving group. Treatment of the substituted compound with tetra alkyl ammonium nitrate displaces the leaving group, substitutes a nitrate ester or a nitrooxy group, for the hydroxy and inverts the 13-stereochemistry to beta . Reduction of the nitrooxy group returns the 13-hydroxy group and retains the 13- beta configuration. The intermediate 13-nitrooxy compounds are themselves potent anti-parasitic agents.</p>
申请公布号 EP0514090(A1) 申请公布日期 1992.11.19
申请号 EP19920304151 申请日期 1992.05.08
申请人 MERCK & CO. INC. 发明人 JONES, TODD K.;MROZIK, HELMUT
分类号 C07D493/22;A01N43/90;A61K31/365;A61P33/00;A61P33/10;C07H19/01 主分类号 C07D493/22
代理机构 代理人
主权项
地址